| Literature DB >> 22827935 |
Eva M Zopf1, Moritz Braun, Stefan Machtens, Jürgen Zumbé, Wilhelm Bloch, Freerk T Baumann.
Abstract
BACKGROUND: Although treatment regimen have improved in the last few years, prostate cancer patients following a radical prostatectomy still experience severe disease- and treatment-related side effects, including urinary incontinence, erectile dysfunction and psychological issues. Despite high incidence rates and the common adverse effects there is a lack of supportive measures for male patients and specific physical exercise recommendations for prostate cancer patients during rehabilitation or in the aftercare are still missing. METHODS/Entities:
Mesh:
Year: 2012 PMID: 22827935 PMCID: PMC3414755 DOI: 10.1186/1471-2407-12-312
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Inclusion and exclusion criteria
| - malignant PCa disease | - metastatic PCa disease |
| - primary treatment involved radical prostatectomy or combination therapy (radical prostatectomy + radiation) | - patients scheduled to receive hormone treatment or (neo-) adjuvant chemotherapy |
| - primary treatment is completed | - radiation as sole treatment |
| - primary treatment is at least 6 weeks, however no longer than 12 weeks ago | - severe cardiac disease (NYHA III-IV) |
| - written consent | - severe mental illness or chronic disease that rules out regular PA |
| | - alcohol, drug or medical abuse |
| | - insufficient German language skills |
| - regular PA of more than 1 hour/week |
PCa: prostate cancer, PA: physical activity, NYHA: New York Heart Association.
Exercise pool of the semi-standardized multi-modal exercise program for prostate cancer patients
| - Nordic walking | - | 50-70% HRmax 11–15 RPE | Improvements in: | |||||
| | | | | -aerobic endurance | ||||
| | | | | -muscle strength | ||||
| | | | | -mobilization | ||||
| | | | | -wellbeing | ||||
| - stretching | 16 | 2-3x 10–15 sec. | Improvements in: | |||||
| | | | | -flexibility | ||||
| - strengthening exercises incl. pelvic floor muscles | 20 | 1. phase: 1–2 sets, 8–10 rep., 30% MVC | Improvements in: | |||||
| | - resistance exercises with equipment or strength training machines | 28 | 2. phase: 2–3 sets, 8–15 rep., 30-50% MVC | -incontinence | ||||
| | | | | -muscle strength (esp. postural muscles) | ||||
| | | | | -flexibility | ||||
| | -ADLs incl. pelvic floor muscles | 16 | 3. phase: 3 sets, 15–20 rep., 50-60% MVC | -wellbeing | ||||
| | | | 4. phase: 3 sets, 12–15 rep., 70% MVC | |||||
| - relaxation exercises | 8 | Depending on exercise and patient’s condition | Improvements in: | |||||
| | - breathing exercises | 5 | ||||||
| | | | | -flexibility | ||||
| | - partner exercises | 6 | | -coordination | ||||
| | - perception and coordination exercises | 27 | | -relaxation skills | ||||
| | - cooperative games | 8 | | -cognitive abilities | ||||
| | | | | - interaction | ||||
| | | | | -cooperation | ||||
| -communication |
ADLs: activities of daily living; HRmax: maximum heart rate; MVC: maximum voluntary contraction; rep.: repetitions; RPE: rating of perceived exertion.
Outcome measures, assessment methods, and assessment time points of the study
| Physical performance | Spiroergometry on treadmill | | x | | x | | x |
| Incontinence | Pad-Test | | x | | x | | x |
| PSA, Testosterone, Endostatin, VEGF | Blood Sample | | x | | x | | x |
| Quality of Life | EORTC-QLQ-C30/PR 25 | x | x | x | x | x | x |
| Erectile Dysfunction | IIEF – Questionnaire | x | x | x | x | x | x |
| Physical Activity Level (MET- Score) | Freiburger Questionnaire of Physical Activity | | x | x | x | x | x |
| Compliance | Compliance Questionnaire | x | x | x | x | x | |
EORTC-QLQ-C30/PR25: European Organization for Research and Treatment of Cancer- Quality of Life Questionnaire- Cancer/Prostate Cancer Module, IG: intervention group, IIEF: International Index of Erectile Function, MET: metabolic equivalent, Post-OP: after surgery/primary treatment, Pre-OP: prior to surgery/primary treatment, PSA: prostate-specific antigen, VEGF: vascular endothelial growth factor.